Experimental diabetes mellitus type 1 increases hippocampal content of kynurenic acid in rats

Background diabetes mellitus (dm) is frequently associated with peripheral and central complications and has recently emerged as a risk factor for cognitive impairment and dementia. kynurenic acid (kyna),a unique tryptophan derivative,displays pleiotropic effects including blockade of ionotropic glutamate and α7 nicotinic receptors. here,the influence of experimental diabetes on kyna synthesis was studied in rat brain. methods dm was induced by i.p. administration of streptozotocin (stz). five weeks later,kyna content and the activity of semi-purified kynurenine aminotransferases (kats) were measured in frontal cortex,hippocampus and striatum of diabetic and insulin-treated rats,using hplc-based methods. results hippocampal but not cortical or striatal kyna concentration was considerably increased during dm,either untreated or treated with insulin (220% and 170% of ctr,respectively). the activity of kynurenine aminotransferase i (kat i) was not affected by dm in all of the studied structures. kat ii activity was moderately increased in cortex (145% of ctr) and hippocampus (126% of ctr),but not in striatum of diabetic animals. insulin treatment normalized cortical but not hippocampal kat ii activity. conclusions a novel factor potentially implicated in diabetic hippocampal dysfunction has been identified. observed increase of kyna level may stem from the activation of endogenous neuroprotection,however,it may also have negative impact on cognition. © 2014 institute of pharmacology,polish academy of sciences.